197 related articles for article (PubMed ID: 28638139)
1. Platelet releasates promote the proliferation of hepatocellular carcinoma cells by suppressing the expression of KLF6.
He AD; Xie W; Song W; Ma YY; Liu G; Liang ML; Da XW; Yao GQ; Zhang BX; Gao CJ; Xiang JZ; Ming ZY
Sci Rep; 2017 Jun; 7(1):3989. PubMed ID: 28638139
[TBL] [Abstract][Full Text] [Related]
2. Platelet derived TGF-β promotes cervical carcinoma cell growth by suppressing KLF6 expression.
He AD; Wang SP; Xie W; Song W; Miao S; Yang RP; Zhu Y; Xiang JZ; Ming ZY
Oncotarget; 2017 Oct; 8(50):87174-87181. PubMed ID: 29152072
[TBL] [Abstract][Full Text] [Related]
3. Kruppel-like factor 6 suppresses growth and invasion of hepatocellular carcinoma cells in vitro and in vivo.
Wen PH; Wang DY; Zhang JK; Wang ZH; Pan J; Shi XY; Yang H; Zhang SJ; Guo WZ
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):666-675. PubMed ID: 27510817
[TBL] [Abstract][Full Text] [Related]
4. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
[TBL] [Abstract][Full Text] [Related]
5. TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.
Bhagyaraj E; Ahuja N; Kumar S; Tiwari D; Gupta S; Nanduri R; Gupta P
Cell Cycle; 2019 Dec; 18(24):3589-3602. PubMed ID: 31739702
[TBL] [Abstract][Full Text] [Related]
6. Metformin suppresses hepatocellular carcinoma cell growth through induction of cell cycle G1/G0 phase arrest and p21CIP and p27KIP expression and downregulation of cyclin D1 in vitro and in vivo.
Cai X; Hu X; Cai B; Wang Q; Li Y; Tan X; Hu H; Chen X; Huang J; Cheng J; Jing X
Oncol Rep; 2013 Nov; 30(5):2449-57. PubMed ID: 24008375
[TBL] [Abstract][Full Text] [Related]
7. Interaction of KLF6 and Sp1 regulates basigin-2 expression mediated proliferation, invasion and metastasis in hepatocellular carcinoma.
Kong LM; Yao L; Lu N; Dong YL; Zhang J; Wang YQ; Liu L; Zhang HL; Huang JG; Liao CG
Oncotarget; 2016 May; 7(19):27975-87. PubMed ID: 27057625
[TBL] [Abstract][Full Text] [Related]
8. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
9. The
Ri K; Kim C; Pak C; Ri P; Om H
Microrna; 2020; 9(1):64-69. PubMed ID: 30868974
[TBL] [Abstract][Full Text] [Related]
10. Combretastatin A-1 phosphate, a microtubule inhibitor, acts on both hepatocellular carcinoma cells and tumor-associated macrophages by inhibiting the Wnt/β-catenin pathway.
Mao J; Wang D; Wang Z; Tian W; Li X; Duan J; Wang Y; Yang H; You L; Cheng Y; Bian J; Chen Z; Yang Y
Cancer Lett; 2016 Sep; 380(1):134-43. PubMed ID: 27349166
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
[TBL] [Abstract][Full Text] [Related]
12. The Eltrombopag antitumor effect on hepatocellular carcinoma.
Kurokawa T; Murata S; Zheng YW; Iwasaki K; Kohno K; Fukunaga K; Ohkohchi N
Int J Oncol; 2015 Nov; 47(5):1696-702. PubMed ID: 26397763
[TBL] [Abstract][Full Text] [Related]
13. Glucose induced activation of canonical Wnt signaling pathway in hepatocellular carcinoma is regulated by DKK4.
Chouhan S; Singh S; Athavale D; Ramteke P; Pandey V; Joseph J; Mohan R; Shetty PK; Bhat MK
Sci Rep; 2016 Jun; 6():27558. PubMed ID: 27272409
[TBL] [Abstract][Full Text] [Related]
14. The SV2 variant of KLF6 is down-regulated in hepatocellular carcinoma and displays anti-proliferative and pro-apoptotic functions.
Hanoun N; Bureau C; Diab T; Gayet O; Dusetti N; Selves J; Vinel JP; Buscail L; Cordelier P; Torrisani J
J Hepatol; 2010 Nov; 53(5):880-8. PubMed ID: 20801538
[TBL] [Abstract][Full Text] [Related]
15. Frequent down-regulation and deletion of KLF6 in primary hepatocellular carcinoma.
Wang S; Kang L; Chen X; Zhou H
J Huazhong Univ Sci Technolog Med Sci; 2010 Aug; 30(4):470-6. PubMed ID: 20714872
[TBL] [Abstract][Full Text] [Related]
16. Protein phosphatase 2A-B55δ enhances chemotherapy sensitivity of human hepatocellular carcinoma under the regulation of microRNA-133b.
Zhuang Q; Zhou T; He C; Zhang S; Qiu Y; Luo B; Zhao R; Liu H; Lin Y; Lin Z
J Exp Clin Cancer Res; 2016 Apr; 35():67. PubMed ID: 27074866
[TBL] [Abstract][Full Text] [Related]
17. A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination.
Ahronian LG; Zhu LJ; Chen YW; Chu HC; Klimstra DS; Lewis BC
Oncogene; 2016 Sep; 35(35):4653-62. PubMed ID: 26876204
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the tumor suppressor Krüppel-like factor 6 (KLF6) by mutation or decreased expression in hepatocellular carcinomas.
Pan XC; Chen Z; Chen F; Chen XH; Jin HY; Xu XY
J Zhejiang Univ Sci B; 2006 Oct; 7(10):830-6. PubMed ID: 16972326
[TBL] [Abstract][Full Text] [Related]
19. Aspafilioside B induces G2/M cell cycle arrest and apoptosis by up-regulating H-Ras and N-Ras via ERK and p38 MAPK signaling pathways in human hepatoma HepG2 cells.
Liu W; Ning R; Chen RN; Huang XF; Dai QS; Hu JH; Wang YW; Wu LL; Xiong J; Hu G; Guo QL; Yang J; Wang H
Mol Carcinog; 2016 May; 55(5):440-57. PubMed ID: 25683703
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein-9 is a potent growth inhibitor of hepatocellular carcinoma and reduces the liver cancer stem cells population.
Jung JW; Yoon SM; Kim S; Jeon YH; Yoon BH; Yang SG; Kim MK; Choe S; Kuo MM
Oncotarget; 2016 Nov; 7(45):73754-73768. PubMed ID: 27650540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]